Showing results (81-90 of 89) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Cancer Science|December 12, 2018
Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinomaYoshiyuki Yamamoto, Motohide Uemura, Masashi Fujita, et al.Scientific Reports|April 12, 2020
Tumour grade significantly correlates with total dysfunction of tumour tissue-infiltrating lymphocytes in renal cell carcinomaAtsunari Kawashima, Takayuki Kanazawa, Yujiro Kidani, et al.Cancer Science|March 16, 2022
Perioperative circulating tumor DNA enables the identification of patients with poor prognosis in upper tract urothelial carcinomaKosuke Nakano, Yoko Koh, Gaku Yamamichi, et al.BJUI Compass|May 4, 2026
Preoperative FAN score predicts survival outcomes after radical cystectomy for bladder cancerYu Ishizuya, Atsunari Kawashima, Shimpei Yamashita, et al.International Immunology|January 18, 2020
Clinical importance of the expression of CD4+CD8+ T cells in renal cell carcinomaKentaro Nishida, Atsunari Kawashima, Takayuki Kanazawa, et al.Cancer Treatment and Research Communications|May 29, 2026
Neutrophil-to-lymphocyte ratio and performance status are associated with increased risk of skin toxicity in patients receiving enfortumab vedotin with or without pembrolizumab for metastatic urothelial carcinomaYujiro Hayashi, Atsunari Kawashima, Yoshiyuki Yamamoto, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2018
High-Fat Diet-Induced Inflammation Accelerates Prostate Cancer Growth via IL6 SignalingTakuji Hayashi, Kazutoshi Fujita, Satoshi Nojima, et al.Japanese Journal of Clinical Oncology|July 20, 2026
Short-term efficacy and safety of enfortumab vedotin plus pembrolizumab as a first-line treatment for advanced urothelial carcinoma regardless of cisplatin eligibilityTakuji Hayashi, Atsunari Kawashima, Yoshiyuki Yamamoto, et al.Cancer Research|May 27, 2021
Gut Microbiota-Derived Short-Chain Fatty Acids Promote Prostate Cancer Growth via IGF1 SignalingMakoto Matsushita, Kazutoshi Fujita, Takuji Hayashi, et al.Pageof 9